Forest Expects Memantine NDA In June; Readies For Benicar Sampling

Forest expects to submit an NDA for the Alzheimer's drug memantine in June, the company told analysts at the Deutsche Bank healthcare conference in Baltimore May 7

More from Archive

More from Pink Sheet